← Evidence map

ArticleJournal of biomedical science2025

A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapy.

Ángel J García-Yagüe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40646550